Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Messinis, I. E.
Right arrow Articles by Seferiadis, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Messinis, I. E.
Right arrow Articles by Seferiadis, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 9, 1827-1832, September 2001
© 2001 European Society of Human Reproduction and Embryology

Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women

Ioannis E. Messinis1,4, Ioannis Papageorgiou1, Spyros Milingos1, Eftichia Asprodini2, George Kollios3 and Konstantinos Seferiadis3

1 Departments of Obstetrics and Gynaecology and 2 Pharmacology, University of Thessalia, Larissa and 3 Department of Biological Chemistry, University of Ioannina, Ioannina, Greece

BACKGROUND: Previous studies have alluded to a role for both oestradiol and progesterone in the secretion of leptin from fat cells in the human, although direct evidence has yet to be obtained. The study aim was to assess serum leptin concentrations in normally cycling women receiving exogenous oestradiol and progesterone. METHODS: Normally cycling women were investigated in an untreated spontaneous cycle (control, n = 10), a cycle treated with oestradiol (oestradiol cycle, n = 10) and a cycle treated with oestradiol plus progesterone (oestradiol+progesterone cycle, n = 6). Oestradiol was given to the women through skin patches on cycle days 2, 3 and 4, and progesterone intravaginally on cycle days 3, 4 and 5. Serum concentrations of leptin, oestradiol, progesterone, FSH and LH were measured in daily blood samples. RESULTS: During the treatment, serum oestradiol and progesterone concentrations increased significantly. In the oestradiol cycles, leptin concentrations were not affected by treatment and did not differ from those in controls. In the oestradiol+progesterone cycles, leptin concentrations (mean ± SEM) increased in all women from cycle day 3 (8.6 ± 1.1 ng/ml) to days 5 (12.2 ± 1.8 ng/ml, P < 0.01) and 6 (11.9 ± 2.0, P < 0.05), and were at these points significantly higher than in the control cycles (P < 0.05). The mean percentage increase from day 3 to the peak concentration on days 5 or 6 was 62.6 ± 6.8%. Leptin concentrations returned to the pretreatment value on day 7, together with the concentrations of oestradiol and progesterone. In the oestradiol+progesterone cycles, leptin concentrations correlated significantly with oestradiol and progesterone concentrations, but not with FSH and LH concentrations. CONCLUSIONS: These results show, for the first time, that leptin secretion can be stimulated in women by the administration of oestradiol plus progesterone. This may explain the increased concentrations of leptin during the luteal phase of the normal menstrual cycle.

Key words: human/leptin/oestradiol/progesterone

4 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, University of Thessalia.22 Papakiriazi street, 41222 Larissa, Greece. E-mail: messinis{at}med.uth.gr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
I. E. Messinis
Ovarian feedback, mechanism of action and possible clinical implications
Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A Sood, E S Ford, and C A Camargo Jr
Association between leptin and asthma in adults
Thorax, April 1, 2006; 61(4): 300 - 305.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Dafopoulos, I. Mademtzis, P. Vanakara, A. Kallitsaris, G. Stamatiou, C. Kotsovassilis, and I. E. Messinis
Evidence That Termination of the Estradiol-Induced Luteinizing Hormone Surge in Women Is Regulated by Ovarian Factors
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 641 - 645.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R. Leminen, T. Raivio, S. Ranta, J. Oehler, H. von Hertzen, O. A Janne, and O. Heikinheimo
Late follicular phase administration of mifepristone suppresses circulating leptin and FSH - mechanism(s) of action in emergency contraception?
Eur. J. Endocrinol., March 1, 2005; 152(3): 411 - 418.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N. G. Mahutte, I. M. Matalliotakis, A. G. Goumenou, S. Vassiliadis, G. E. Koumantakis, and A. Arici
Inverse correlation between peritoneal fluid leptin concentrations and the extent of endometriosis
Hum. Reprod., June 1, 2003; 18(6): 1205 - 1209.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
C. P. Lambert, D. H. Sullivan, and W. J. Evans
Effects of Testosterone Replacement and/or Resistance Training on Interleukin-6, Tumor Necrosis Factor Alpha, and Leptin in Elderly Men Ingesting Megestrol Acetate: A Randomized Controlled Trial
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2003; 58(2): M165 - 170.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.